The following table presents the calculation of basic and diluted net loss per share of common stock for the periods indicated:


	Three Months Ended						Six Months Ended
	June 30,						June 30,
(In thousands, except share and per share data)	2026			2025			2026			2025
	(unaudited)						(unaudited)
Net loss attributable to common stockholders	$	(12,701	)	$	(10,407	)	$	(19,716	)	$	(20,871	)
Shares used to compute net loss per common stock, basic and diluted		809,122			28,994			561,567			22,268
Net loss per share attributable to common stockholders, basic and diluted	$	(15.70	)	$	(358.94	)	$	(35.11	)	$	(937.26	)

Basic net loss per share is calculated by dividing net loss by the weighted average number of common stock outstanding during the period. Diluted net loss per share is computed by dividing net loss by the weighted average number of shares of common stock, and certain common stock equivalents outstanding for the period. Common stock equivalents are only included when their effect is dilutive. The Company's potential securities, including warrants, convertible preferred series stock and other common stock equivalents, were excluded because their effect is anti-dilutive. For the prior periods presented, there is no difference in the number of shares used to compute basic and diluted shares outstanding.

The following are the other common stock equivalents of the Company for the six months ended June 30, 2026 and for the year ended December 31, 2025:


	June 30,		December 31,
	2026		2025
	(unaudited)
Options issued and outstanding		5,293		5,601
Inducement options issued and outstanding		—		15
Options available for grant under stock option plans		11,060		200
Restricted stock units issued and outstanding		4,421		5,020
Warrants issued and outstanding		148,171		105,953
Total		168,945		116,789